496 related articles for article (PubMed ID: 36480479)
21. Real-world effectiveness of a single dose of mpox vaccine in males.
Wolff Sagy Y; Zucker R; Hammerman A; Markovits H; Arieh NG; Abu Ahmad W; Battat E; Ramot N; Carmeli G; Mark-Amir A; Wagner-Kolasko G; Duskin-Bitan H; Yaron S; Peretz A; Arbel R; Lavie G; Netzer D
Nat Med; 2023 Mar; 29(3):748-752. PubMed ID: 36720271
[TBL] [Abstract][Full Text] [Related]
22. The CDC Domestic Mpox Response - United States, 2022-2023.
McQuiston JH; Braden CR; Bowen MD; McCollum AM; McDonald R; Carnes N; Carter RJ; Christie A; Doty JB; Ellington S; Fehrenbach SN; Gundlapalli AV; Hutson CL; Kachur RE; Maitland A; Pearson CM; Prejean J; Quilter LAS; Rao AK; Yu Y; Mermin J
MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):547-552. PubMed ID: 37200231
[TBL] [Abstract][Full Text] [Related]
23. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey).
Dukers-Muijrers NHTM; Evers Y; Widdershoven V; Davidovich U; Adam PCG; Op de Coul ELM; Zantkuijl P; Matser A; Prins M; de Vries HJC; den Heijer C; Hoebe CJPA; Niekamp AM; Schneider F; Reyes-Urueña J; Croci R; D'Ambrosio A; van der Valk M; Posthouwer D; Ackens R; Ter Waarbeek H; Noori T; Hoornenborg E
Front Public Health; 2022; 10():1058807. PubMed ID: 36684959
[TBL] [Abstract][Full Text] [Related]
24. Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
Cohn H; Bloom N; Cai GY; Clark JJ; Tarke A; Bermúdez-González MC; Altman DR; Lugo LA; Lobo FP; Marquez S; ; Chen JQ; Ren W; Qin L; Yates JL; Hunt DT; Lee WT; Crotty S; Krammer F; Grifoni A; Sette A; Simon V; Coelho CH
Lancet Infect Dis; 2023 Nov; 23(11):1302-1312. PubMed ID: 37475115
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response - United States, May 17-October 6, 2022.
Kava CM; Rohraff DM; Wallace B; Mendoza-Alonzo JL; Currie DW; Munsey AE; Roth NM; Bryant-Genevier J; Kennedy JL; Weller DL; Christie A; McQuiston JH; Hicks P; Strid P; Sims E; Negron ME; Iqbal K; Ellington S; Smith DK
MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1449-1456. PubMed ID: 36355615
[TBL] [Abstract][Full Text] [Related]
26. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
Muller MP; Navarro C; Wilson SE; Shulha HP; Naus M; Lim G; Padhi S; McGeer A; Finkelstein M; Liddy A; Bettinger JA;
Vaccine; 2024 Jan; 42(3):535-540. PubMed ID: 38199921
[TBL] [Abstract][Full Text] [Related]
27. Mpox Outbreak - Los Angeles County, California, May 4-August 17, 2023.
Leonard CM; Poortinga K; Nguyen E; Karan A; Kulkarni S; Cohen R; Garrigues JM; Marutani AN; Green NM; Kim AA; Sey K; Pérez MJ
MMWR Morb Mortal Wkly Rep; 2024 Jan; 73(2):44-48. PubMed ID: 38236779
[TBL] [Abstract][Full Text] [Related]
28. Reducing Vaccination Disparities During a National Emergency Response: The US Mpox Vaccine Equity Pilot Program.
Bautista GJ; Madera-Garcia V; Carter RJ; Schwitters A; Byrkit R; Carnes N; Prejean J;
J Public Health Manag Pract; 2024 Jan-Feb 01; 30(1):122-129. PubMed ID: 37678261
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Public Health Contact Tracing for Mpox Among Gay, Bisexual, and Other Men Who Have Sex With Men-10 US Jurisdictions, May 17-July 31, 2022.
Cope AB; Kirkcaldy RD; Weidle PJ; Jackson DA; Laramee N; Weber R; Rowse J; Mangla A; Fox B; Saunders KE; Taniguchi K; Usagawa L; Cahill ME; Harrington P; Ricketts EK; Harbi K; Malec L; Templin TG; Drociuk D; Hannibal T; Klos R; Bernstein KT
Am J Public Health; 2023 Jul; 113(7):815-818. PubMed ID: 37141555
[No Abstract] [Full Text] [Related]
30. Mpox in people with past infection or a complete vaccination course: a global case series.
Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
[TBL] [Abstract][Full Text] [Related]
31. A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events - Georgia, August 27-September 5, 2022.
Millman AJ; Denson DJ; Allen ML; Malone JA; Daskalakis DC; Durrence D; Rustin RC; Toomey KE;
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1382-1883. PubMed ID: 36301799
[TBL] [Abstract][Full Text] [Related]
32. Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.
Copen CE; Delaney KP; Agnew-Brune C; Berry I; Griffin I; Hassan R; Oakley LP; Wondmeneh S; Rhodes T; Gillani S; Lee M; Ashley P; Willut C; Mangla AT; Waltenburg MA; Jackson DA;
Sex Transm Dis; 2024 Jan; 51(1):54-60. PubMed ID: 37889944
[TBL] [Abstract][Full Text] [Related]
33. Mpox vaccine acceptability among people experiencing homelessness in San Francisco - October-November 2022.
Filardo TD; Prasad N; Waddell CJ; Persad N; Pellegrini GJ; Borne D; Janssen J; Bejarano A; Marx GE; Mosites E
Vaccine; 2023 Sep; 41(39):5673-5677. PubMed ID: 37591706
[TBL] [Abstract][Full Text] [Related]
34. Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.
van Ewijk CE; Miura F; van Rijckevorsel G; de Vries HJ; Welkers MR; van den Berg OE; Friesema IH; van den Berg PR; Dalhuisen T; Wallinga J; Brandwagt D; van Cleef BA; Vennema H; Voordouw B; Koopmans M; van der Eijk AA; Swaan CM; Te Wierik MJ; Leenstra T; Op de Coul E; Franz E; ;
Euro Surveill; 2023 Mar; 28(12):. PubMed ID: 36951783
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela M; Hernando V; Olmedo C; Coma E; Martínez M; Moreno-Perez D; Lorusso N; Vázquez Torres M; Barbas Del Buey JF; Roig-Sena J; Pastor E; Galmés Truyols A; Artigues Serra F; Sancho Martínez RM; Latasa Zamalloa P; Pérez Martínez O; Vázquez Estepa A; García Rojas AJ; Barreno Estévez AI; Sánchez-Migallón Naranjo A; Pérez Martín JJ; Peces Jiménez P; Morales Romero R; Castilla J; García Cenoz M; Huerta Huerta M; Boone ALD; Macías Ortiz MJ; Álvarez Río V; Rodríguez Recio MJ; Merino Díaz M; Berradre Sáenz B; Villegas-Moreno MT; Limia A; Diaz A; Monge S;
Clin Infect Dis; 2024 Feb; 78(2):476-483. PubMed ID: 37864849
[TBL] [Abstract][Full Text] [Related]
36. Epidemiologic and Clinical Features of Mpox in Adults Aged >50 Years - United States, May 2022-May 2023.
Eustaquio PC; Salmon-Trejo LAT; McGuire LC; Ellington SR
MMWR Morb Mortal Wkly Rep; 2023 Aug; 72(33):893-896. PubMed ID: 37590262
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.
Merad Y; Gaymard A; Cotte L; Perpoint T; Alfaiate D; Godinot M; Becker A; Cannesson O; Batalla AS; Oria-Yassir F; Landré S; Morfin F; Bouscambert M; Valour F; Ader F; Conrad A
Euro Surveill; 2022 Dec; 27(50):. PubMed ID: 36695469
[TBL] [Abstract][Full Text] [Related]
38. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department.
Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B
Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of Mpox Vaccine Recipients Among a Sample of Men Who Have Sex With Men With Presumed Exposure to Mpox.
Abara WE; Sullivan P; Carpino T; Sanchez T; Atkins K; Delaney K; Edwards OW; Hannah M; Baral S; Ogale Y; Galloway E; Lansky A
Sex Transm Dis; 2023 Jul; 50(7):458-461. PubMed ID: 36940183
[TBL] [Abstract][Full Text] [Related]
40. Addressing mpox at a Frontline Community Health Center: Lessons for the Next Outbreak.
Allan-Blitz LT; Khan T; Elangovan K; Smith K; Multani A; Mayer KH
Public Health Rep; 2024; 139(3):294-300. PubMed ID: 37846528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
